Myovant Sciences Ltd Stock News

Myovant Sciences (MYOV), a healthcare company focused on developing innovative treatments for women's health and prostate cancer, and HealthyWomen, the nation’s leading independent, nonprofit health

Initiative to spotlight diverse, personal stories about menstruation in partnership with storytelling nonprofit The Moth HealthyWomen joins Female Forward...

Myovant Sciences Ltd (NYSE:MYOV) major shareholder Chemical Co. Ltd. Sumitomo purchased 140,000 shares of the business’s stock in a transaction dated Wednesday, April 8th. The shares were purchased

Tables of the top insider purchases and sales filed with the SEC on 4/9/20, based on dollar value. Dollar values often do not equate with significance when it c

Credit Suisse AG raised its position in Myovant Sciences Ltd (NYSE:MYOV) by 8.9% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 16,202 shares of the compan

Tables of the top insider purchases and sales filed with the SEC on 4/7/20, based on dollar value. Dollar values often do not equate with significance when it c

Myovant Sciences (MYOV) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well

Myovant Sciences (MYOV) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well

Myovant Sciences Ltd (NYSE:MYOV)’s share price dropped 8.4% on Tuesday . The company traded as low as $7.83 and last traded at $7.84, approximately 869,609 shares changed hands during mid-day tradin

Myovant Sciences Ltd (NYSE:MYOV) major shareholder Chemical Co. Ltd. Sumitomo bought 140,000 shares of the stock in a transaction that occurred on Monday, April 6th. The shares were purchased at an av

Cubist Systematic Strategies LLC increased its position in shares of Myovant Sciences Ltd (NYSE:MYOV) by 21.7% during the 4th quarter, according to the company in its most recent 13F filing with the S

Myovant Sciences Ltd (NYSE:MYOV) shares rose 5.9% on Monday after an insider bought additional shares in the company. The company traded as high as $9.00 and last traded at $8.56, approximately 1,031,

Tables of the top insider purchases and sales filed with the SEC on 4/3/20, based on dollar value. Dollar values often do not equate with significance when it c

Myovant Sciences Ltd (NYSE:MYOV) major shareholder Chemical Co. Ltd. Sumitomo acquired 140,000 shares of the business’s stock in a transaction on Thursday, April 2nd. The shares were purchased at an

Myovant Sciences Ltd (NYSE:MYOV) – Research analysts at SVB Leerink upped their FY2020 EPS estimates for Myovant Sciences in a research report issued on Tuesday, March 31st. SVB Leerink analyst A. F